Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation and Depletion (2019 - 2025)

Biodesix (BDSX) has disclosed Depreciation and Depletion for 7 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion fell 519.93% year-over-year to -$2.3 million, compared with a TTM value of $482000.0 through Dec 2025, down 85.62%, and an annual FY2025 reading of $482000.0, down 85.62% over the prior year.
  • Depreciation and Depletion was -$2.3 million for Q4 2025 at Biodesix, down from $1.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.0 million in Q3 2024 and bottomed at -$2.3 million in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $347750.0, with a median of $400000.0 recorded in 2022.
  • The sharpest move saw Depreciation and Depletion soared 3780.0% in 2024, then tumbled 519.93% in 2025.
  • Year by year, Depreciation and Depletion stood at -$186000.0 in 2021, then soared by 326.88% to $422000.0 in 2022, then tumbled by 103.55% to -$15000.0 in 2023, then skyrocketed by 3780.0% to $552000.0 in 2024, then crashed by 519.93% to -$2.3 million in 2025.
  • Business Quant data shows Depreciation and Depletion for BDSX at -$2.3 million in Q4 2025, $1.0 million in Q3 2025, and $900000.0 in Q2 2025.